Clinical Trial Update: A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating everolimus in patients with metastatic pancreatic neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: European Institute of Oncology | Conditions: Pancreatic Neuroendocrine Tumour Metastatic | Phase 2 | Status: COMPLETED